Abstract
Anesthetics exert multiple effects on the central nervous system through altering synaptic transmission, but the mechanisms for this process are poorly understood. PDZ domain-mediated protein interactions play a central role in organizing signaling complexes around synaptic receptors for efficient signal transduction. We report here that clinically relevant concentrations of inhalational anesthetics dose-dependently and specifically inhibit the PDZ domain-mediated protein interaction between PSD-95 or PSD-93 and the N-methyl-D-aspartate receptor or neuronal nitric-oxide synthase. These inhibitory effects are immediate, potent, and reversible and occur at a hydrophobic peptide-binding groove on the surface of the second PDZ domain of PSD-95 in a manner relevant to anesthetic action. These findings reveal the PDZ domain as a new molecular target for inhalational anesthetics.
Original language | English (US) |
---|---|
Pages (from-to) | 36669-36675 |
Number of pages | 7 |
Journal | Journal of Biological Chemistry |
Volume | 278 |
Issue number | 38 |
DOIs | |
State | Published - Sep 19 2003 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology